<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">patients </span>
   <span class="font30">headache </span>
   <span class="font25">ICHD </span>
   <span class="font24">CPH </span>
   <span class="font22">Headache </span>
   <span class="font20">diagnosis </span>
   <span class="font19">children </span>
   <span class="font19">years </span>
   <span class="font18">&amp;lt; </span>
   <span class="font18">MOH </span>
   <span class="font17">chronic </span>
   <span class="font17">(.%) </span>
   <span class="font17">data </span>
   <span class="font17">{border-style </span>
   <span class="font17">criteria </span>
   <span class="font16">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">age </span>
   <span class="font16">migraine </span>
   <span class="font16">pediatric </span>
   <span class="font15">Chronic </span>
   <span class="font15">adolescents </span>
   <span class="font15">study </span>
   <span class="font15">Figure </span>
   <span class="font14">.). </span>
   <span class="font14">significant </span>
   <span class="font13">(.%), </span>
   <span class="font13">clinical </span>
   <span class="font13">daily </span>
   <span class="font13">duration </span>
   <span class="font13">frequency </span>
   <span class="font13">frequent </span>
   <span class="font13">headaches </span>
   <span class="font13">prevalence </span>
   <span class="font13">prophylactic </span>
   <span class="font13">University </span>
   <span class="font13">associated </span>
   <span class="font13">attack </span>
   <span class="font13">did </span>
   <span class="font13">drug </span>
   <span class="font13">drugs </span>
   <span class="font13">efficacy </span>
   <span class="font13">features </span>
   <span class="font13">overuse </span>
   <span class="font13">symptoms </span>
   <span class="font13">topiramate </span>
   <span class="font13">Pain </span>
   <span class="font13">amitriptyline </span>
   <span class="font13">population </span>
   <span class="font13">primary </span>
   <span class="font13">px; </span>
   <span class="font13">treatment </span>
   <span class="font13">undefined </span>
   <span class="font13">{font-family </span>
   <span class="font12">(ICHD </span>
   <span class="font12">Italy </span>
   <span class="font12">font-size </span>
   <span class="font12">higher </span>
   <span class="font12">possible </span>
   <span class="font12">risk </span>
   <span class="font12">.–.; </span>
   <span class="font12">Neurol. </span>
   <span class="font12">Neurology </span>
   <span class="font12">Papetti </span>
   <span class="font12">age. </span>
   <span class="font12">compared </span>
   <span class="font12">diagnosed </span>
   <span class="font12">double; </span>
   <span class="font12">included </span>
   <span class="font12">main </span>
   <span class="font12">medical </span>
   <span class="font12">medication </span>
   <span class="font12">patients. </span>
   <span class="font12">probable </span>
   <span class="font12">therapy </span>
   <span class="font12">used </span>
   <span class="font12">version </span>
   <span class="font12">vs. </span>
   <span class="font11">(%) </span>
   <span class="font11">(.% </span>
   <span class="font11">(OR </span>
   <span class="font11">.%, </span>
   <span class="font11">./j.-...x </span>
   <span class="font11">Cephalalgia </span>
   <span class="font11">Children </span>
   <span class="font11">Insubria </span>
   <span class="font11">Rome </span>
   <span class="font11">age, </span>
   <span class="font11">and/or </span>
   <span class="font11">attacks </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">collection </span>
   <span class="font11">effective </span>
   <span class="font11">episodic </span>
   <span class="font11">groups </span>
   <span class="font11">including </span>
   <span class="font11">obtained </span>
   <span class="font11">pCM </span>
   <span class="font11">patients, </span>
   <span class="font11">qualitative </span>
   <span class="font11">response </span>
   <span class="font11">results </span>
   <span class="font11">solid; </span>
   <span class="font11">younger </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">&amp;gt; </span>
   <span class="font11">.), </span>
   <span class="font11">./head. </span>
   <span class="font11">According </span>
   <span class="font11">Amitriptyline </span>
   <span class="font11">Bambino </span>
   <span class="font11">CTTH </span>
   <span class="font11">Child </span>
   <span class="font11">Classification </span>
   <span class="font11">Congress </span>
   <span class="font11">Gesù </span>
   <span class="font11">However, </span>
   <span class="font11">International </span>
   <span class="font11">Medication </span>
   <span class="font11">Study </span>
   <span class="font11">according </span>
   <span class="font11">adolescent </span>
   <span class="font11">adolescents: </span>
   <span class="font11">adult </span>
   <span class="font11">bold </span>
   <span class="font11">concerning </span>
   <span class="font11">conducted </span>
   <span class="font11">considered </span>
   <span class="font11">courier; </span>
   <span class="font11">criteria. </span>
   <span class="font11">criterion </span>
   <span class="font11">different </span>
   <span class="font11">distribution </span>
   <span class="font11">duration, </span>
   <span class="font11">em; </span>
   <span class="font11">females, </span>
   <span class="font11">follow-up </span>
   <span class="font11">followed </span>
   <span class="font11">history </span>
   <span class="font11">increase </span>
   <span class="font11">pharmacological </span>
   <span class="font11">presence </span>
   <span class="font11">present </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">pt;} </span>
   <span class="font11">receive </span>
   <span class="font11">reported </span>
   <span class="font11">shorter </span>
   <span class="font11">showed </span>
   <span class="font11">statistical </span>
   <span class="font11">subtypes </span>
   <span class="font11">therapies </span>
   <span class="font11">topiramate, </span>
   <span class="font11">years, </span>
   <span class="font11">young </span>
  </p>
 </body>
</html>
